Enterprise Value (EV)
Paying user area
Try for free
Eli Lilly & Co. pages available for free this week:
- Balance Sheet: Assets
- Balance Sheet: Liabilities and Stockholders’ Equity
- Common-Size Income Statement
- Analysis of Profitability Ratios
- Analysis of Liquidity Ratios
- Common Stock Valuation Ratios
- Price to FCFE (P/FCFE)
- Capital Asset Pricing Model (CAPM)
- Current Ratio since 2005
- Total Asset Turnover since 2005
The data is hidden behind: . Unhide it.
Get full access to the entire website from $10.42/mo, or
get 1-month access to Eli Lilly & Co. for $24.99.
This is a one-time payment. There is no automatic renewal.
We accept:
Current Enterprise Value (EV)
Eli Lilly & Co., current enterprise value calculation
| Current share price (P) | |
| No. shares of common stock outstanding | |
| US$ in thousands | |
| Common equity (market value)1 | |
| Add: Noncontrolling interests (per books) | |
| Total equity | |
| Add: Short-term borrowings and current maturities of long-term debt (per books) | |
| Add: Long-term debt, excluding current maturities (per books) | |
| Total equity and debt | |
| Less: Cash and cash equivalents | |
| Less: Short-term investments | |
| Enterprise value (EV) | |
Based on: 10-K (reporting date: 2024-12-31).
1 Common equity (market value) = Share price × No. shares of common stock outstanding
= ×
Historical Enterprise Value (EV)
Eli Lilly & Co., EV calculation
Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31).
1 Data adjusted for splits and stock dividends.
2 Closing price as at the filing date of Eli Lilly & Co. Annual Report.
3 2024 Calculation
Common equity (market value) = Share price × No. shares of common stock outstanding
= ×
The data indicates a significant upward trend across all presented financial items over the five-year period.
- Common equity (market value)
- This metric shows continuous strong growth, increasing from approximately 198 billion US dollars in 2020 to over 822 billion US dollars by the end of 2024. The most substantial jump occurs between 2022 and 2023, where the value more than doubles, suggesting a significant appreciation in market valuation or company performance.
- Total equity
- Total equity follows a similar pattern to common equity, starting at about 198 billion US dollars in 2020 and reaching above 822 billion US dollars in 2024. This parallel trend indicates that the company’s book equity and market valuation are closely aligned, with both reflecting robust growth and financial strengthening over the period analyzed.
- Total equity and debt
- Total equity and debt increase steadily from roughly 215 billion US dollars in 2020 to nearly 856 billion US dollars by 2024. The rise mirrors the increase in equity, and the magnitude of the increase suggests that debt levels have also scaled up, though proportionally less dramatically than equity. The consistent growth in this aggregate figure points to expansion financed through a combination of equity and borrowed funds.
- Enterprise value (EV)
- Enterprise value progresses closely with total equity and debt, moving from about 211 billion US dollars in 2020 to over 852 billion US dollars in 2024. The near parity between enterprise value and total equity plus debt indicates stability in the valuation approach, with EV reflecting the comprehensive market value of the company including debt obligations. The sharp increases in EV align with those seen in other financial measures, reinforcing the overall trend of growth and increased company scale.
Overall, the data illustrates a consistent and substantial growth trajectory in both market value and book value measures. The alignment across common equity, total equity, total equity plus debt, and enterprise value indicates a coherent financial growth pattern with scaled leverage, supporting a narrative of expanding company value and strengthened capital structure over the observed period.